In this interview, Dr. Andrew Saxon discusses practical aspects of prescribing psychotropic medications for patients with stimulant use disorders. He emphasizes the use of behavioral interventions, such as contingency management and cognitive–behavioral therapy, as first-line treatment strategies and presents data regarding the use of specific medications, such as mirtazapine, methylphenidate, bupropion, prazosin, and disulfiram, among others, for the treatment of patients with stimulant use disorders.
- Provider:Medical Academy, LLC
- Activity Link: https://psychopharmacologyinstitute.com/publication/pharmacotherapies-for-stimulant-use-disorder-interview-2691?utm_source=PARS+ACCME&utm_medium=PARS+ACCME&utm_campaign=PARS+ACCME
- Start Date: 2022-12-01 06:00:00
- End Date: 2022-12-01 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.75 hours
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Performance
- Provider Ship: Jointly Provided
- Registration: Limited
Subscribe
Login
0 Comments
Oldest